ID   S6B45
AC   CVCL_A1SE
DR   cancercelllines; CVCL_A1SE
DR   Wikidata; Q105510939
RX   PubMed=1720489;
RX   PubMed=8510328;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6018; IL6.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M538 ! MM-S1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
RX   PubMed=1720489; DOI=10.1016/0145-2126(91)90110-f;
RA   Suzuki A., Takahashi T., Okuno Y., Fukumoto M., Fukui H.,
RA   Koishihara Y., Ohsugi Y., Ohno Y., Imura H.;
RT   "Estimation of interleukin 6 production by reverse
RT   transcriptase-polymerase chain reaction in four human myeloma cell
RT   lines.";
RL   Leuk. Res. 15:1043-1050(1991).
//
RX   PubMed=8510328; DOI=10.11406/rinketsu.34.423;
RA   Takahashi T., Okuno Y., Ohsugi Y.;
RT   "Growth characteristics of a human myeloma cell line transfected with
RT   IL-6 cDNA.";
RL   Rinsho Ketsueki 34:423-426(1993).
//